Picture of DURECT logo

DRRX — DURECT News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Durect Corp Expected To Post A Loss Of 17 Cents A Share: Earnings Preview

* DURECT Corp  DRRX.OQ   DRRX.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 13 for
the period ending June 30 2024
    * The Cupertino California-based  company is expected to
report a
13.2% increase in revenue to $1.975 million from $1.74 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for DURECT Corp is for a
loss
of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DURECT Corp
is
$6.75​, above​ its last closing price of $1.29. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.16       -0.17      -0.12     Beat    29.4
 Mar. 31 2024  -0.22       -0.22      -0.25     Missed  -13.6
 Dec. 31 2023              -0.33      -0.10     Beat    69.9​
 Jan. 1 0001   -0.42       -0.42      -0.14     Beat    66.7
 ​​Jun.        -0.48       -0.51      -0.42     Beat    17.6
 30 2023                                                
 Mar. 31 2023  -0.52       -0.53      -0.47     Beat    11.3​
 Dec. 31 2022  -0.54       -0.55      -0.46     Beat    15.9
 Sep. 30 2022  -0.10       -0.10      -0.10     Met     0
 This summary was machine generated November 12 at 03:47 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on DURECT

See all news